Kiren Ubhi

3.4k citations

36 papers · 2.0k indexed · h-index 26

Neurology top 1%
Cellular and Molecular Neuroscience top 2%
Physiology top 2%
Neurology top 1%
Molecular Biology

Co-authors: Eliezer Masliah Edward Rockenstein Anthony Adame Michael Mante Christina Patrick Chandra Inglis Phillip A. Low Brian Spencer
Topics: Parkinson's Disease Mechanisms and Treatments (17 papers)Alzheimer's disease research and treatments (13 papers)Cholinesterase and Neurodegenerative Diseases (13 papers)
Cited by: Neurology Cellular and Molecular Neuroscience
Journals: Journal of NeuroscienceSHILAP Revista de lepidopterologíaPLoS ONE
Partner nations: United States Germany Austria

In The Last Decade

Kiren Ubhi

36 papers receiving 1.9k citations

Peers

Countries citing papers authored by Kiren Ubhi

Since Specialization

Citations

This map shows the geographic impact of Kiren Ubhi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kiren Ubhi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kiren Ubhi more than expected).

Fields of papers citing papers by Kiren Ubhi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kiren Ubhi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kiren Ubhi. The network helps show where Kiren Ubhi may publish in the future.

Co-authorship network of co-authors of Kiren Ubhi

This figure shows the co-authorship network connecting the top 25 collaborators of Kiren Ubhi. A scholar is included among the top collaborators of Kiren Ubhi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kiren Ubhi. Kiren Ubhi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Neuro-peptide treatment with Cerebrolysin improves the survival of neural stem cell grafts in an APP transgenic model of Alzheimer disease 2015 ·Stem Cell Research ·Edward Rockenstein,Paula Desplats,Kiren Ubhi,Michael Mante,Jazmin Florio,Anthony Adame,Stefan Winter,(unknown),D. Meier,Eliezer Masliah	38
2	Neuropeptide Treatment with Cerebrolysin Enhances the Survival of Grafted Neural Stem Cell in an α-Synuclein Transgenic Model of Parkinson's Disease 2015 ·SHILAP Revista de lepidopterología ·Edward Rockenstein,Paula Desplats,Kiren Ubhi,Michael Mante,Jazmin Florio,Anthony Adame,Stefan Winter,(unknown),D. Meier,Herbert Moessler,Eliezer Masliah	6
3	Reducing C-Terminal-Truncated Alpha-Synuclein by Immunotherapy Attenuates Neurodegeneration and Propagation in Parkinson's Disease-Like Models 2014 ·Journal of Neuroscience ·Dora Games,Elvira Valera,Brian Spencer,Edward Rockenstein,Michael Mante,Anthony Adame,Christina Patrick,Kiren Ubhi,Silke Nuber,(unknown),Wagner Zago,Peter Seubert,Robin Barbour,Dale Schenk,Eliezer Masliah	244
4	Cerebrolysin modulates pronerve growth factor/nerve growth factor ratio and ameliorates the cholinergic deficit in a transgenic model of Alzheimer's disease 2012 ·Journal of Neuroscience Research ·Kiren Ubhi,Edward Rockenstein,Rubén Antonio Vázquez‐Roque,Michael Mante,Chandra Inglis,Christina Patrick,Anthony Adame,Margaret Fahnestock,Edith Doppler,(unknown),Herbert Moessler,Eliezer Masliah	55
5	Fluoxetine rescues impaired hippocampal neurogenesis in a transgenic A53T synuclein mouse model 2012 ·European Journal of Neuroscience ·Zacharias Kohl,Beate Winner,Kiren Ubhi,Edward Rockenstein,Michael Mante,(unknown),(unknown),(unknown),Eliezer Masliah,Jürgen Winkler	86
6	Differential Effects of UCHL1 Modulation on Alpha-Synuclein in PD-Like Models of Alpha-Synucleinopathy 2012 ·PLoS ONE ·Anna Cartier,Kiren Ubhi,Brian Spencer,Rubén Antonio Vázquez‐Roque,Kori Kosberg,Lawrence Fourgeaud,(unknown),Christina Patrick,Edward Rockenstein,Gentry N. Patrick,Eliezer Masliah	58
7	Fluoxetine ameliorates behavioral and neuropathological deficits in a transgenic model mouse of α-synucleinopathy 2012 ·Experimental Neurology ·Kiren Ubhi,Chandra Inglis,Michael Mante,Christina Patrick,Anthony Adame,Brian Spencer,Edward Rockenstein,Verena May,Jürgen Winkler,Eliezer Masliah	69
8	Autophagy in Dementias 2011 ·Brain Pathology ·Christine Lund Kragh,Kiren Ubhi,(unknown),Eliezer Masliah	54
9	Beneficial effects of a neurotrophic peptidergic mixture persist for a prolonged period following treatment interruption in a transgenic model of Alzheimer's disease 2011 ·Journal of Neuroscience Research ·Edward Rockenstein,Kiren Ubhi,(unknown),Sarah Michael,Edith Doppler,(unknown),Chandra Inglis,Michael Mante,Anthony Adame,X.A. Alvarez,Herbert Moessler,Eliezer Masliah	18
10	Neurotoxic effects of the HCV core protein are mediated by sustained activation of ERK via TLR2 signaling 2011 ·Journal of NeuroVirology ·Amy Paulino,Kiren Ubhi,Edward Rockenstein,Anthony Adame,Leslie Crews,Scott Letendre,Ronald J. Ellis,Ian Everall,Igor Grant,Eliezer Masliah	30
11	Reduced hypocretin (orexin) levels in dementia with Lewy bodies 2010 ·Neuroreport ·Stephanie Lessig,Kiren Ubhi,Douglas Galasko,Anthony Adame,(unknown),(unknown),Michael F. Chang,Lawrence A. Hansen,Eliezer Masliah	33
12	Neurodegeneration in a Transgenic Mouse Model of Multiple System Atrophy Is Associated with Altered Expression of Oligodendroglial-Derived Neurotrophic Factors 2010 ·Journal of Neuroscience ·Kiren Ubhi,Edward Rockenstein,Michael Mante,Chandra Inglis,Anthony Adame,Christina Patrick,Kristen Whitney,Eliezer Masliah	125
13	Alpha-synuclein deficient mice are resistant to toxin-induced multiple system atrophy 2010 ·Neuroreport ·Kiren Ubhi,Edward Rockenstein,Michael Mante,Chandra Inglis,Anthony Adame,Christina Patrick,Eliezer Masliah	11
14	Progressive accumulation of amyloid‐β oligomers in Alzheimer’s disease and in amyloid precursor protein transgenic mice is accompanied by selective alterations in synaptic scaffold proteins 2010 ·FEBS Journal ·(unknown),Leslie Crews,Kiren Ubhi,Lawrence A. Hansen,Anthony Adame,Anna Cartier,David P. Salmon,Douglas Galasko,Sarah Michael,Jeffrey N. Savas,John R. Yates,Charles Glabe,Eliezer Masliah	179
15	Neurofibrillary and neurodegenerative pathology in APP-transgenic mice injected with AAV2-mutant TAU: neuroprotective effects of Cerebrolysin 2009 ·Acta Neuropathologica ·Kiren Ubhi,Edward Rockenstein,Edith Doppler,Michael Mante,Anthony Adame,Christina Patrick,Margarita Trejo,Leslie Crews,Amy Paulino,Herbert Moessler,Eliezer Masliah	34
16	Aβ exacerbates the neuronal dysfunction caused by human tau expression in a Drosophila model of Alzheimer's disease 2009 ·Experimental Neurology ·(unknown),Catherine M. Cowan,Kiren Ubhi,(unknown),Tracey A. Newman,David Shepherd,Amritpal Mudher	74
17	Mitochondrial inhibitor 3‐nitroproprionic acid enhances oxidative modification of alpha‐synuclein in a transgenic mouse model of multiple system atrophy 2009 ·Journal of Neuroscience Research ·Kiren Ubhi,Phil Hyu Lee,Anthony Adame,Chandra Inglis,Michael Mante,Edward Rockenstein,Nadia Stefanova,Gregor K. Wenning,Eliezer Masliah	61
18	Lovastatin ameliorates α-synuclein accumulation and oxidation in transgenic mouse models of α-synucleinopathies 2009 ·Experimental Neurology ·Andrew O. Koob,Kiren Ubhi,Johan F. Paulsson,Jeffery W. Kelly,Edward Rockenstein,Michael Mante,Anthony Adame,Eliezer Masliah	90
19	Rifampicin reduces α-synuclein in a transgenic mouse model of multiple system atrophy 2008 ·Neuroreport ·Kiren Ubhi,Edward Rockenstein,Michael Mante,Christina Patrick,Anthony Adame,(unknown),Clifford W. Shults,Eliezer Masliah	55
20	A comparison of the neuronal dysfunction caused by Drosophila tau and human tau in a Drosophila model of tauopathies 2007 ·Invertebrate Neuroscience ·Kiren Ubhi,(unknown),Tracey A. Newman,David Shepherd,Amritpal Mudher	33

About Kiren Ubhi

Kiren Ubhi is a scholar working on Neurology, Neurology and Pharmacology, having authored 36 papers that have together received 2.0k indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (17 papers), Alzheimer's disease research and treatments (13 papers) and Cholinesterase and Neurodegenerative Diseases (13 papers). The work is most often cited by research in Neurology (590 citations), Neurology (1.0k citations) and Cellular and Molecular Neuroscience (806 citations). Kiren Ubhi has collaborated with scholars based in United States, Germany and Austria. Frequent co-authors include Eliezer Masliah, Edward Rockenstein, Anthony Adame, Michael Mante, Christina Patrick, Chandra Inglis, Phillip A. Low, Brian Spencer, Silke Nuber and Elvira Valera. Their work appears in journals such as Journal of Neuroscience, SHILAP Revista de lepidopterología and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact